These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11477166)

  • 1. ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.
    Nowack R; Grab I; Flores-Suarèz LF; Schnülle P; Yard B; van der Woude FJ
    Nephrol Dial Transplant; 2001 Aug; 16(8):1631-7. PubMed ID: 11477166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
    Csernok E; Ahlquist D; Ullrich S; Gross WL
    Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
    Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
    Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
    Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL
    Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
    Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
    J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
    Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
    Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis.
    Segelmark M; Phillips BD; Hogan SL; Falk RJ; Jennette JC
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):769-74. PubMed ID: 12965902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
    Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
    Schultz DR; Diego JM
    Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
    Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
    Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
    J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
    Radice A; Vecchi M; Bianchi MB; Sinico RA
    Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis.
    Gisslén K; Wieslander J; Westberg G; Herlitz H
    J Intern Med; 2002 Feb; 251(2):129-35. PubMed ID: 11905588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA and IgG subclasses.
    Segelmark M; Wieslander J
    Adv Exp Med Biol; 1993; 336():71-5. PubMed ID: 8296678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.